DE BURLO GROUP INC - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 201 filers reported holding CANTEL MEDICAL CORP in Q4 2015. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
DE BURLO GROUP INC ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q4 2019$475,000
-5.2%
6,7000.0%0.10%
-15.0%
Q3 2019$501,000
-12.6%
6,700
-5.6%
0.11%
+0.9%
Q2 2019$573,000
+20.6%
7,1000.0%0.11%
+16.7%
Q1 2019$475,000
-29.8%
7,100
-22.0%
0.10%
-36.8%
Q4 2018$677,000
-29.9%
9,100
-13.3%
0.15%
-16.0%
Q3 2018$966,000
-6.4%
10,5000.0%0.18%
-17.0%
Q2 2018$1,032,000
-11.7%
10,5000.0%0.22%
-14.5%
Q1 2018$1,169,000
+7.2%
10,500
-0.9%
0.26%
+15.4%
Q4 2017$1,090,000
+9.2%
10,6000.0%0.22%0.0%
Q3 2017$998,000
+18.7%
10,600
-1.9%
0.22%
+17.6%
Q2 2017$841,000
-72.0%
10,800
-71.2%
0.19%
-71.2%
Q1 2017$3,003,000
-45.7%
37,500
-46.6%
0.65%
-51.6%
Q4 2016$5,528,000
+22.7%
70,200
+21.5%
1.35%
+7.7%
Q3 2016$4,507,000
-16.8%
57,800
-26.6%
1.25%
-4.5%
Q2 2016$5,415,000
-48.1%
78,800
-46.1%
1.31%
-56.7%
Q1 2016$10,439,000
+51.2%
146,300
+31.7%
3.02%
+86.0%
Q4 2015$6,903,000
-1.9%
111,100
-10.5%
1.62%
-1.7%
Q3 2015$7,036,000
+5.6%
124,1000.0%1.65%
+18.5%
Q2 2015$6,660,000
+28.4%
124,100
+13.6%
1.39%
+35.7%
Q1 2015$5,187,000
+34.1%
109,200
+22.1%
1.03%
+31.3%
Q4 2014$3,867,00089,4000.78%
Other shareholders
CANTEL MEDICAL CORP shareholders Q4 2015
NameSharesValueWeighting ↓
DIKER MANAGEMENT LLC 1,028,295$45,183,00028.17%
NexWave Capital Partners LLC 84,802$3,751,0006.00%
Leonard Green & Partners, L.P. 2,600,000$114,244,0005.94%
Champlain Investment Partners, LLC 3,935,670$172,933,0001.18%
Aurora Investment Counsel 19,848$1,137,0000.94%
Brown Capital Management 2,531,558$111,237,0000.92%
Advantage Alpha Capital Partners LP 73,615$3,235,0000.75%
Conestoga Capital Advisors, LLC 789,154$34,675,0000.70%
WASHINGTON CAPITAL MANAGEMENT, INC 11,000$483,0000.50%
Intrinsic Edge Capital Management LLC 151,077$6,638,0000.45%
View complete list of CANTEL MEDICAL CORP shareholders